A regulatory domain that directs lineage-specific expression of a skeletal matrix protein gene in the sea urchin embryo by Sucov, Henry M. et al.
A regulatory domain that directs lineage- 
specific expression of a skeletal matrix 
protein gene in the sea urchin embryo 
Henry M. Sucov, Barbara R. Hough-Evans, Roberta R. Franks, Roy J. Britten, and Eric H. Davidson 
Division of Biology, California Institute of Technology, Pasadena, Califomia 91125 USA 
DNA sequences derived from the 5' region of a gene coding for the 50-kD skeletal matrix protein (SM50) of sea 
urchin embryo spicules were linked to the CAT reporter gene and injected into unfertilized eggs. CAT mRNA 
and enzyme were synthesized from these fusion constructs in embryos derived from these eggs, and in situ 
hybridization with a CAT antisense RNA probe demonstrated that expression is confined to skeletogenic 
mesenchyme cells. A mean of 5.5 of the 32-blastula-stage skeletogenic mesenchyme cells displayed CAT 
mRNA (range 1-15), a result consistent with earlier measurements indicating that incorporation of the 
exogenous injected DNA probably occurs in a single blastomere during early cleavage. In vitro mutagenesis and 
deletion experiments howed that CAT enzyme activity in the transgenic embryos is enhanced 34-fold by 
decreasing the number of SM50 amino acids at the amino-terminus of the fusion protein from 43 to 4. cis- 
regulatory sequences that are sufficient o promote lineage-specific spatial expression in the embryo are located 
between -440 and + 120 with respect o the transcriptional initiation site. 
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The skeletal elements, or spicules, of the sea urchin em- 
bryo are produced by cells of four equivalent lineages 
that derive from the fourth-cleavage micromeres (for re- 
view of the origin and differentiation of the skeletogenic 
mesenchyme see Davidson 1986). At fifth cleavage the 
founder cells of the skeletogenic lineages are separated 
from their sister cells by an asymmetrically positioned 
plane of cleavage, the orientation of which is normal to 
the primordial animal-vegetal axis of the egg. The 
smaller polar derivatives of this cleavage give rise to the 
eight 'small micromeres,' the ultimate contribution of 
which remains obscure (however, see Pehrson and 
Cohen 1986), and the larger derivatives are the four 
clonal precursors of the skeletogenic mesenchyme 
(these are the VAMk, VOMk, and the two VLMk cells of 
the canonical sea urchin embryo lineage map; Davidson 
1986, Fig. 4.5; Cameron et al. 1987). Three cleavage divi- 
sions ensue, giving rise to 32 descendants of the skeleto- 
genic founder cells that all display the molecular and 
structural specializations required for spicule formation. 
At the swimming blastula stage the presumptive skele- 
togenic cells are located in a single-cell-thick disc at the 
vegetal pole of the embryo, surrounding the eight small 
micromeres. In embryos of Strongylocentrotus pur- 
puratus, with which the work described herein was car- 
ried out, the skeletogenic precursors ingress into the 
blastocoel at 12-16 hr postfertilization (16°C). Once 
having assumed their free wandering mesenchymal 
habit, the cells proceed to explore the interior blastocoel 
wall, and then as gastrulation begins (-30 hr postfertili- 
zation) they coalesce bilaterally on the future oral side of 
the archenteron and commence the generation of the 
two triradiate spicules. Approximately one further divi- 
sion of these cells occurs during the gastrular period of 
development, he major phase of skeletogenic activity. 
During this phase the skeletogenic ells align them- 
selves along the blastocoel wall and form syncytial 
columns, within which are secreted the elongated skel- 
etal rods. These extend from the initial spicular foci at 
the oral side of the base of the archenteron toward the 
region where the mouth will form, and also posteriorly, 
in the aboral direction, ultimately forcing the ectoderm 
into the characteristic elongate triangular form of the 
echinoid pluteus larva. The mineral component of the 
skeletal structures is a 20 : 1 CaCOa : MgCO3 complex, 
which is deposited within a protein template secreted by 
the skeletogenic mesenchyme cells. Benson et al. (1986) 
solubilized the matrix and found that it is composed of 
about 10 different proteins, of which a major component 
is a 50-kD glycoprotein moiety. The mRNA and gene 
coding for this protein, which is known as SMS0 {50-kD 
spicule matrix protein), have been cloned, sequenced, 
and characterized (Benson et al. 1987; Sucov et al. 1987). 
As expected, the SM50 gene is expressed exclusively 
in skeletogenic mesenchyme (Benson et al. 1987), 
though its transcripts first become detectable many 
hours prior to the onset of skeletogenesis, about the 
time of ingression. However, at this early stage there are 
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~10 SMS0 mRNA molecules per skeletogenic mesen- 
chyme cell, while in postgastrular stages, when these 
cells are executing their climax skeletogenic function, 
the prevalence of SM50 message approaches 200 mole- 
cules per cell (Killian and Wilt 1988). The SM50 gene 
can be regarded as a cardinal molecular marker for the 
specific and particular process of differentiation under- 
gone by the skeletogenic mesenchyme lineages. It is 
likely a member of a battery of similarly regulated genes, 
including those genes coding for the other spicule ma- 
trix proteins; a gene coding for a mesenchyme cell-sur- 
face glycoprotein known as mspl30, which may be re- 
quired for normal migration and/or for Ca 2+ uptake 
(Carson et al. 1985; Wessel and McClay 1985; Anstrom 
et al. 1987; Leaf et al. 1987); and genes coding for several 
unidentified mesenchyme-specific mRNAs and proteins 
(Harkey and Whiteley 1983; Harkey 1985; Harkey et al. 
1988). 
The differentiation of skeletogenic mesenchyme is
from the beginning an autonomous process. Thus, in 
culture, isolated fourth-cleavage micromeres display a 
succession of activities that correspond to the phases of 
their normal development in situ. They divide several 
times, acquire motility, and display the changes in adhe- 
sive properties expected from their behavior in the em- 
bryo. They then carry out skeletogenesis in vitro with 
good efficiency, though they tend to produce straight 
rather than brachiated skeletal rods (Okazaki 1975; 
Harkey and Whiteley 1980, 1983; McCarthy and Spiegel 
1983; Carson et al. 1985). Many changes in the synthesis 
of specific proteins that are correlated with the differen- 
tiation of these ceils also take place in vitro in cultures 
originated with micromeres (Harkey and Whiteley 1983; 
Pittman and Ernst 1984). Most significantly for our 
present purpose, expression of the SM50 gene occurs au- 
tonomously in cultures of dissociated micromeres, and 
it has been shown rigorously by Stephens et al. (1988) 
that SM50 expression requires no intercellular contact. 
Thus, blastomeres i olated at second cleavage, i.e., prior 
to micromere formation, and maintained in culture 
under conditions in which no contact of the mitotic 
progeny is permitted, begin to produce SM50 mRNA on 
schedule. SM50 transcripts accumulate in these single 
cell cultures in an appropriate number of cells, and to 
within 50% of the normal evel of expression in vivo. It 
follows that the pattern of expression of this lineage-spe- 
cific gene depends entirely on factors inherited spatially 
in the course of the geometrically predetermined se- 
quence of cleavages by which the founder cells are segre- 
gated. The lack of requirement for intercellular induc- 
tive interaction for differentiation of the skeletogenic 
mesenchyme is unusual among known sea urchin em- 
bryo lineages, most of which require specific interac- 
tions for their normal fates to be realized (see Discussion 
for references). The micromeres themselves derive from 
an element of egg cytoplasm which is defined by its 
polar location with respect o the primordially organized 
animal-vegetal xis of the egg. A reasonable interpreta- 
tion is that spatial regulation f genes uch as SM50 that 
are expressed exclusively in the skeletogenic lineage 
occurs by cis-trans interactions of localized maternal 
factors with regulatory regions of that gene, or of other 
genes which produce factors that have this function (Da- 
vidson and Britten 1971). In this paper we report initial 
steps toward the requisite xperimental analysis. We 
have made use of a gene transfer system (Flytzanis et al. 
1985; McMahon et al. 1985; Hough-Evans et al. 1987, 
1988) to demonstrate correct spatial regulation of a fu- 
sion construct driven by the regulatory domain of the 
SM50 gene. These experiments show that sequences in- 
cluded within 440 nucleotides of the transcription i iti- 
ation site suffice to promote active expression that is 
confined to the skeletogenic mesenchyme c lls. 
Results 
A fusion gene under control of SM50 regulatory 
sequences i expressed specifically in skeletogenic 
mesenchyme c lls 
The organization of the SM50 gene and of several con- 
structs used in these experiments, in which the CAT re- 
porter gene was fused to various 5' regions of the SM50 
gene sequence, is displayed schematically in Figure 1, a 
and b. The body of the SM50 gene consists of two exons, 
213 and 1682 nucleotides long, respectively, separated 
by a 7.1-kb intron. Translation begins within the first 
exon at position + 110 with respect o the transcription 
initiation site. The first 15 of the 34 amino acids en- 
coded by the initial exon apparently specify a signal pep- 
tide, and the splice site divides the 35th codon. An ini- 
tial series of studies was carried out with the construct 
designated SM50. CAT in Figure lb. This construct 
contains 2.2 kb of 5'-flanking sequence from the SM50 
gene, plus the entire first exon and intron, fused just 
within the second exon to the coding region of the 
vector pSVOCAT (Gorman et al. 1982), so as to maintain 
a continuous open reading frame. As shown in Figure 1 c 
the predicted fusion protein is expected to contain 43 
amino acids derived from the SMS0 gene (including the 
15-amino-acid signal peptide), 14 amino acids from the 
vector sequence preceding the CAT coding region, and 
then the 231 residues of the CAT enzyme protein. 
The SM50 • CAT fusion was linearized at the unique 
BamHI site, and microinjected into unfertilized S. pur- 
puratus eggs. The embryos were harvested 48-50 hr 
after fertilization, at the early pluteus tage, for CAT en- 
zyme assay. At this stage the skeletal rods are length- 
ening rapidly and the endogenous SM50 RNA is present 
at maximum level (Benson et al. 1987; Killian and Wilt 
1988). Table 1 demonstrates that CAT enzyme activity 
in the transgenic embryos was present at two to three 
times the background level of the assay, measured in 
uninjected control embryos. The absolute level of CAT 
activity measured in these experiments i , of course, an 
arbitrary function of the number of embryos pooled for 
each sample, which was set at a relatively low level 
(25-40/sample) so as to minimize the number of in- 
jected embryos required. However, CAT activity would 
be expected to be low on a per embryo basis if the con- 
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Figure 1. Structure of SM50 gene and of CAT gene fusions. (a) Organization of the SMS0 gene. Exons of the SM50 gene are depicted 
as solid rectangles. The genomic lone from which the CAT constructs were d rived is shown above (see Materials and methods). 
Restriction sites: (Bg) BgllI; (K) KpnI; (R) EcoRV~ (S) Sail. (b) SM50. CAT constructs. Regions derived from exons of the SM50 gene are 
depicted as filled rectangles; flanking and intron sequences a  thin lines. The CAT coding region and SV40 polyadenylation region 
derived from pSV40CAT are depicted as a striped box. The vector and nonessential SV40 sequences appended to the 5' end of each 
construct are not shown. (B} BamHI; (Sp} SphI. The scale in a and b is the same. (c) Amino-terminal sequence of the expected fusion 
protein, and nucleotide sequence of the junction region of SM50. CAT. The protein coding region derived from the first exon of the 
SM50 gene is shown at the top. Below is shown the junction between sequences of the second SM50 exon and the CAT vector, which 
were ligated together at the indicated Sail site. The boxed ATG codon (codon 58} is the original translation initiation codon of the 
bacterial CAT protein. The first 43 amino acids of the open reading frame of the construct derive from SM50, and residues 44-57 are 
from translation of vector sequences preceding the beginning of the CAT coding region. Numbering begins with the SMS0 initiation 
codon. {d I Oligonucleotide-directed mutagenesis and deletion of the sequence coding for the signal peptide. The coding strand of the 
first exon is shown on the top line of sequence. Below is the 37-nucleotide oligomer used for mutagenesis. The location of the 
introduced Sail restriction site and the translation product of the resultant open reading frame are shown. 
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Table 1. CAT enzyme activity in transgenic S. purpuratus embryos bearing various SM50. CAT fusion constructs 
Experiment 1 Experiment 2 Experiment 3 
percent units percent units percent units 
Construct acetylation CAT/embryo acetylation CAT/embryo acetylation CAT/embryo 
SM50-CAT 0.13 3.6 x 10 -7 0.24 3.0 x 10 -7 0.14 1.3 × 10 -7 
SM50A- CAT 0.24 1.0 x 10 -6 
2.2. CAT 1.20 9.5 x 10 -6 1.81 3.3 x 10 -6 0.98 1.7 x 10 -6 
Uninjected controls 0.07 -- 0.08 -- 0.08 -- 
In experiment 1 each value represents he average of two samples (SM50. CAT, 2.2. CAT, uninjected controls) or three samples 
(SM50A • CAT), each sample containing 25-45 injected embryos. In experiments 2 and 3 each value represents one sample of 46 
injected embryos. 
struct is expressed only in skeletogenic mesenchyme 
cells, as these constitute only -6% of total cells in the 
pluteus-stage embryo. 
To determine what cell types in the transgenic em- 
bryos express the SM50. CAT fusion gene, we carried 
out in situ hybridization using a CAT antisense [3H]- 
RNA probe (Hough-Evans et al. 1987, 1988). For this ex- 
periment he embryos were harvested at the early mes- 
enchyme blastula stage, when skeletogenic mesen- 
chyme cells are the sole occupants of the blastocoel, and 
are hence easy to identify. The embryo at this stage con- 
sists of approximately 500 cells, of which about 400 are 
ectodermal, 60 comprise the vegetal plate from which 
will later derive secondary mesenchyme, gut, muscle, 
and the larval rudiment, and 32 are cells belonging to the 
skeletogenic mesenchyme lineages (Davidson 1986, Fig. 
4.5). Complete or nearly complete series of sections of 
77 embryos derived from eggs that had been injected 
with SMS0. CAT and retained good morphology were 
examined, and of these 61 showed autoradiographic 
signal. For the purposes of these experiments, a positive 
signal was one in which five or more grains were clus- 
tered over any given cell. This level of signal is easily 
visualized over background, which on the average was 
less than 0.4 grains/cell, as observed over uninjected 
control embryo sections. With the exception of four 
questionable cases, labeling was clearly confined to ske- 
letogenic mesenchyme c lls already in the blastocoel, or 
to the polar region of the thickened vegetal wall from 
which the presumptive skeletogenic mesenchyme cells 
ingress. Representative examples of these in situ hybrid- 
izations are reproduced in Figure 2. Expression over cells 
of the polar ectoderm wall was expected, as the endoge- 
nous SM50 gene is active prior to ingression of the ske- 
letogenic mesenchyme, as early as the 120-cell stage 
(Benson et al. 1987; Killian and Wilt 1988), and the em- 
bryos were collected while some were in the process of 
ingression. Of the 61 embryos which contained CAT 
mRNA, 30 displayed label only in the primary mesen- 
chyrne, 10 only in the polar vegetal region of the ecto- 
derm, and 21 in both. The four embryos that showed 
some low level labeling over cells that were possibly not 
of the correct lineage included two in which labeling 
was marginally above background over a single cell at 
what appeared to be the lateral side of the vegetal plate; 
a third in which what appeared to be a single animal 
pole ectodermal cell was labeled; and one embryo in 
which three cells were labeled, one each in three adja- 
cent sections, at the lateral side of the vegetal plate and 
at the animal pole. The significance of these cases is 
doubtful, since occasional uninjected control embryo 
sections contained adventitious grain clusters that could 
have been counted as positive labeling over individual 
cells, and in addition it is possible to misidentify mesen- 
chyme cells if they have applied themselves closely to 
the ectoderm wall or have been crushed against it in the 
course of sectioning. These examples notwithstanding, 
the results of the in situ hybridization experiments dem- 
onstrate clearly that the SM50 sequence included in 
SM50. CAT suffices to promote expression specifically 
in the skeletogenic mesenchyme lineages. 
Mosaic expression of the exogenous fusion ge e 
DNA microinjected into unfertilized sea urchin egg cy- 
toplasm is ligated rapidly into a concatenated form prior 
to first cleavage (McMahon et al. 1985). The DNA then 
enters the nuclear compartment, and in most embryos is 
stably incorporated into at least one blastomere during 
the first several c eavages (Hough-Evans et al. 1988). In- 
corporation appears to occur randomly with respect o 
cell lineage. Thereafter the exogenous sequences are be- 
queathed to all the progeny of the blastomere in which 
the incorporation event occurred, and it replicates at 
about the same rate as does the DNA of its host cell 
lineage (Franks et al. 1988; Hough-Evans et al. 1988). 
The mosaic incorporation pattern is ultimately manifest 
in a mosaic pattern of expression, the fraction of cells 
within a given tissue that express the transgene de- 
pending upon the timing and location of the initial inte- 
gration event. 
In the 77 embryos examined by in situ hybridization 
in the experiment just described, the median number of 
ingressed skeletogenic mesenchyme cells clearly identi- 
fied in the sections was 19. This value ranged from zero 
to 52, the latter probably representing embryos that had 
completed ingression, in which many mesenchyme c lls 
had been sectioned and were represented in successive 
sections. In the following analysis, only ingressed mes- 
enchyme cells were considered, as their progenitors are 
difficult to distinguish while they are still resident 
within the vegetal ectodermal wall. Mesenchyme cells 
within the blastocoel could in most cases be distin- 
guished easily. Eleven embryos that retained five or less 
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Figure 2. In situ hybridizations ofembryos expressing SM50. CAT Sections of six different embryos at mesenchyme blastula stage 
are shown. The sections are oriented sothat the vegetal pole is at bottom. The embryo in b was distorted during sectioning~ itsvegetal 
pole is at bottom right. The number of labeled mesenchyme ceils, and the number of mesenchyme c lls present in each panel is: {a) 5 
of 6, {b} 4 of 13, {c} 3 of 5, {d) 5 of 9, {el 3 of 14, and If) 1 of 9. The single labeled cell in the section shown i  f was the only labeled 
mesenchyme cell Iof a total of 43} labeled in this embryo. Labeling at the vegetal pole is seen (slightly out of focusl in the embryo 
section of c. 
ingressed mesenchyme cells were excluded from the 
analysis. The remaining 66 embryos were examined in- 
dividually to determine the fraction of ingressed mesen- 
chyme cells that displayed label on hybridization with 
the CAT antisense [3HIRNA probe. Results are pre- 
sented in Figure 3a, where, for ease of comparison, data 
for all embryos are normalized to 32 cells. Seventeen of 
the 66 embryos did not show label in any of their mesen- 
chyme cells, either because they had integrated the ex- 
ogenous DNA exclusively into nonskeletogenic lineages 
or had failed to incorporate it at all. Generally only a few 
mesenchyme cells were labeled in each embryo, al- 
though in some a significant fraction displayed autora- 
diographic grains. For labeled embryos the mean fraction 
of labeled mesenchyme cells was 5.5/32, or 17.2%. 
These numbers could be underestimated, as we do not 
know whether all the cells that expressed the transgene 
displayed significant autoradiographic label at the expo- 
sure used. Reference to he lineage from which the ske- 
letogenic mesenchyme derives hows that incorporation 
of the DNA into a single ancestral blastomere of this 
lineage from the 4-cell to the 32-cell stage would result 
in labeling of 25 % of the mesenchyme c lls, while inte- 
gration into a single blastomere of this lineage at the 64- 
cell stage would result in 12.5% of the mesenchyme 
cells labeled. In the inset in Figure 3a the same data are 
classed in such a way that each bar represents embryos 
in which the DNA could have entered the skeletogenic 
mesenchyme lineage at a given cleavage, e.g., for the 
class labeled 6.3%, or 2/32 cells labeled, the implication 
would be that the DNA was incorporated at the seventh 
cleavage~ for the class labeled 12.5%, or 4/32, at the 
sixth cleavage~ and for the class labeled 25%, at any time 
between the second and fifth cleavages. However, a fur- 
ther labeled restriction is imposed by the high fraction of 
embryos displaying some label in mesenchyme cells, 
i.e., 49/66. A single random incorporation event any- 
where in the embryo after the horizontal third cleavage 
would result in no more than 50% embryos with any 
labeled mesenchyme cells, since only the lower four 
cells of the eight-cell embryo contribute to the skeleto- 
genic mesenchyme. In addition, three embryos fall in 
the class labeled 50%, probably indicating incorporation 
at the two-cell stage. Thus, it is unlikely that the large 
25% class in the inset in Figure 3a is due to incorpora- 
tion as late as the fifth cleavage. We may conclude that 
incorporation occurred in about two-thirds of the em- 
bryos {i.e., those falling in the classes labeled 12.5% and 
25%1 sometime between the s cond cleavage and sixth 
cleavage, with a few earlier and some later incorpora- 
tions as well. 
A similar analysis was carried out with embryos de- 
rived from eggs injected with a slightly different con- 
struct which displays the same spatial expression pat- 
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Figure 3. Mosaic expression of SM50-CAT 
constructs in mesenchyme c lls labeled by in 
situ hybridization. The fraction of labeled mes- 
enchyme cells in 66 embryos grown from eggs 
injected with SM50-CAT (a) or 35 embryos 
grown from eggs injected with 2.2PL • CAT (b) is 
shown. The fraction of labeled cells for each em- 
bryo was normalized to 32 cells, rounded to the 
nearest 0.2. Of the labeled embryos, the mean 
normalized number of labeled cells is 5.5 (a) and 
6.4 (b) (arrows). Below the horizontal axis of a is 
shown the boundaries that were used to group 
the embryos into mosaicism classes as shown in 
the inset. The model used to group the embryos 
assumes that all of the injected CAT DNA is 
stably integrated into a single cell during early 
cleavage (see Hough-Evans et al. 1988) and de- 
tectably expressed in all the progeny which be- 
come primary mesenchyme. The theoretical 
number of labeled cells can be described by the 
function 2 -n, where n = 1 for an integration 
event at the two-cell stage; n = 2 for the 4- 
through 32-cell stage; and n = 3, 4, 5 for the 64-, 
120-, and 240-cell stages. The range used to 
group the experimental data of a for the inset 
was 2 -n(-+°-sl. 
tern as SM50. CAT (viz. the BglII-BamHI fragment of 
2.2PL • CAT; see Fig. 1 and below). Thirty-five of 37 em- 
bryos in this experiment displayed six or more ingressed 
mesenchyme cells, and the mean number of mesen- 
chyme cells per embryo was 16. The distribution of la- 
beled mesenchyme cells in this sample is shown in 
Figure 3b. This distribution is obviously almost the 
same as that of Figure 3a (the mean of Fig. 3b is 6.4/32 
cells vs. 5.5/32 cells for Fig. 3a). A detailed analysis of 
incorporation frequency of DNA injected into S. pur- 
puratus egg cytoplasm was recently carried out by 
Hough-Evans et al. (1988), in which a different construct 
was used, and the fraction of all embryo cells bearing the 
exogenous DNA was determined irectly by DNA in 
situ hybridization. This study indicated that in about 
three-fourths of the embryos the exogenous DNA could 
have been incorporated in a single second-, third-, or 
fourth-cleavage blastomere. While incorporation into 
the skeletogenic mesenchyme lineage certainly occurs 
during these same stages, the largest class of labeled em- 
bryos in this study is that in which incorporation appar- 
ently occurred at the sixth cleavage. Thus, micromeres 
and their descendants may be slightly more refractory to 
incorporation than is the remainder of the embryo, or, 
because they individually include severalfold less cyto- 
plasmic volume than do the meso- or macromeres (Ernst 
et al. 1980), they may simply have a smaller chance of 
inherit ing the exogenous DNA concatenate. 
Deletion of SM50 amino acid sequence from the fusion 
gene product 
As shown in Figure l c the fusion product of the 
SM50. CAT construct contains 43 amino acids derived 
from the amino-terminus of the SM50 protein, including 
the putative signal peptide. As described in the fol- 
lowing section, we measured the amount of CAT 
mRNA generated in embryos bearing the SM50. CAT 
fusion, and comparison with earlier studies carried out 
with a different CAT fusion (Flytzanis et al. 1987) indi- 
cated that the level of enzyme activity measured in the 
present experiments was over 10-fold lower than would 
be expected from the level of transcript observed. A pos- 
sible explanation was that the signal peptide might lead 
to secretion into the endoplasmic reticulum, and/or 
modification and loss of the CAT enzyme activity. The 
sequence coding for the signal peptide was thus deleted 
by oligonucleotide-directed mutagenesis, as indicated in 
Figure ld and Materials and methods. The fusion protein 
coded by the deletion SM50A. CAT now includes only 
23 SM50 amino acids. However, as shown in Table 1, 
SM50A" CAT produces only about twofold more CAT 
enzyme activity than does the parental construct. Thus, 
there is no evidence that the intracellular trafficking 
presumably mediated by the signal peptide significantly 
affects extractable CAT enzyme activity. 
The SM50A. CAT construct contains a new SalI re- 
striction site at the point of the deletion, as shown in 
Figure ld. This site was fused in frame to the SalI site 
immediately preceding the CAT coding sequence, to 
produce a third construct, called 2.2. CAT (Fig. lb). This 
includes the same upstream SM50 gene sequences as 
does SM50-CAT, but codes for only four amino-ter- 
minal  SM50 amino acid residues. The remainder of the 
first exon, the large intron, and the fragment of the 
second exon included in the other constructs o far con- 
sidered have been removed. A three-way comparison of 
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the constructs indicates that 2.2. CAT generates 25-fold 
greater CAT activity per average embryo than does 
SM50. CAT {Table 1, experiment 1). In other experi- 
ments, 2.2. CAT produced 11-fold and 13-fold greater 
activity than did SM50. CAT {Table 1, experiments 2 
and 3). As shown below, the SM50 regulatory sequences 
required for proper spatial regulation are retained in 
2.2. CAT, and therefore the much higher level of CAT 
activity displayed by this construct is not a result of ec- 
topic expression of the transgene in additional cell types 
of the embryo. 
On the evidence thus far, this enhanced CAT enzyme 
activity could result either from removal of an intra- 
genic site of transcriptional repression located within 
the intron or exon sequences deleted with the Sa/I frag- 
ment in the construction of 2.2 • CAT, or from removal 
of an amino-terminal protein sequence that in some way 
interferes with CAT enzyme function or accumulation. 
We show in the following that the latter is the correct 
explanation. 
Probe excess titration of CAT mRNA in transgenic 
embryos 
The amount of CAT mRNA generated in early pluteus- 
stage embryos bearing SM50-CAT or 2 .2-CAT was 
measured by single-strand probe excess titration, to 
assay directly the transcriptional productivity of these 
constructs. Two experiments were carried out in which 
u_n_fertilized eggs were injected with SM50. CAT and 
2.2. CAT, and samples were taken at 50 hr postfertiliza- 
tion for measurement of CAT enzyme activity, CAT 
DNA content, and CAT mRNA content. The CAT 
assays from these samples are those already discussed 
(experiments 2 and 3, Table 1 I. A measurement of CAT 
DNA content in the embryos of experiment 2 is shown 
in Figure 4a, obtained by slot blot hybridization of DNA 
extracted from transgenic embryos, to a probe consisting 
of the sense strand of the CAT mRNA sequence. In this 
experiment the average mbryo in the sample injected 
with SM50. CAT contained 8 x 104 molecules of the 
exogenous construct, and the corresponding average 
value for the 2.2. CAT sample was 1.8 x 104 exogenous 
DNA molecules per embryo. The difference may have 
been due to inadvertent introduction of more 
SM50. CAT DNA during injection. Previous studies 
have shown that for a given batch of eggs the amount of 
DNA retained and replicated during development de- 
pends mainly  on the amount injected and not at all on 
the sequence, providing that the injected molecules are 
>1-2  kb long (McMahon et al. 1985; Flytzanis et al. 
1987; Livant et al. 19881. 
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Figure 4. Titration of fusion gene transcripts. (a) Quantitation ofCAT DNA in experimental embryos. DNA was extracted from 612 
carrier embryos plus 30 experimental embryos grown 50 hr {early pluteusl from eggs injected with SMS0. CAT or 2.2. CAT. The yield 
of DNA, determined by DAPI fluorescence measurement, was 1.5 g.g [approximately complete] for each experimental sample. Next, 
1.25 ~g of DNA from the SMS0. CAT sample {slot 1) or the 2.2- CAT sample [slot 2), or a known amount of linearized CAT DNA 
mixed with 1.25 ~g of carrier embryo DNA (slots 4-9) was denatured, affixed to nitrocellulose, and hybridized with a probe specific 
for CAT sequences. Standards in slots 4-9 are 0, 0.5, 1, 2, 5, and 10 x 106 molecules of CAT DNA, respectively. Slot 3 contains no 
DNA. Conversion of hybridized counts per minute, measured by scintillation counting of excised bands, to molecules of CAT DNA 
and indicates that the SMS0. CAT sample contained 2 x 106 molecules of CAT DNA and the 2.2. CAT sample 0.4 x 106 molecules 
CAT DNA. (b) Titration of the CyIIIa message. Increasing amounts of RNA extracted from 18,800 50-hr carrier embryos plus 1455 
50-hr experimental embryos expressing SMS0. CAT (o) or 2.2. CAT (A), or from control (unin/ected) embryos (e) were hybridized in 
solution to an excess of a2P-labeled antisense Cyllla RNA probe. Unhybridized RNA was digested with RNase A and T1, and TCA-pre- 
cipitable counts per minute measured and plotted versus input mass of sea urchin RNA. The slope of the line is a function of message 
prevalence and is independent of RNA recovery between the samples. Lines were fitted to data points by linear least squares regres- 
sion. (c) Titration of the SM50. CAT message. Symbols and method are as in b, except hat RNA samples were hybridized to an 
antisense CAT RNA probe. 
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The samples of transgenic embryos to be used for CAT 
mRNA measurement were collected together with a 13- 
fold excess of carrier embryos grown in parallel from un- 
injected eggs, and total RNA was extracted (see Mate- 
rials and methods). To control for recovery and integrity 
of the extracted RNA, the quantity of CyIIIa cytoskel- 
etal actin mRNA was determined, as the number of 
transcripts of this mRNA species had been measured by 
titration in S. purpuratus embryos in an earlier study 
(Lee et al. 1986). The CyIIIa titrations are shown in 
Figure 4b, and the parallel CAT mRNA titrations in 
Figure 4c. As shown in Figure 4b, the SM50. CAT and 
2.2. CAT samples contained almost equivalent concen- 
trations of CyIIIa message, corresponding to 4.4 x 10 4 
and 4.1 x 104 CyIIIa transcripts per embryo, respec- 
tively, while the uninjected embryo control indi- 
cated 2.7 x 104 transcripts per embryo. Lee et al. (1986) 
found 5.8 x 10 4 CyIIIa transcripts per embryo at 36 hr 
and 8.8 x 104 at 65 hr. Interpolating, we would expect 
from these measurements about 7 x 10  4 CyIIIa tran- 
scripts per embryo at 50 hr. We assume the measure- 
ments of Lee et al. (1986) to be the more accurate since 
they were carried out on relatively large rather than mi- 
croscale samples of embryos, and thus conclude that we 
recovered about 60% of the correct number of CyIIIa 
transcripts. However, since this factor would cause an 
underestimate in the actual amount of CAT mRNA in 
the experimental samples of less than a factor of 2, and 
since the two experimental samples are in this respect 
indistinguishable, we have not normalized the CAT 
mRNA measurements shown in Figure 4c to a level that 
would assume 100% CyIIIa mRNA recovery. A direct 
conversion of the CAT mRNA titration shown to tran- 
script prevalence yields a value of 1.8 x 104 CAT 
mRNA molecules per embryo in the SM50. CAT 
sample, and 6.4 x 103 CAT mRNA molecules per em- 
bryo in the 2.2. CAT sample. As expected there is no 
CAT mRNA in the uninjected control, though this 
sample is undegraded, since it displays ample CyIIIa 
mRNA (Fig. 4b). The 2.8-fold greater amount of CAT 
mRNA in the SM50. CAT sample may be accounted for 
by the fourfold greater average content of CAT DNA re- 
tained in the SMS0. CAT embryos in this experiment, 
and certainly does not explain the 12-fold lower recovery 
of CAT enzyme activity. In any case, assuming that the 
two message species are translated with equal efficiency, 
since they share the same 5' untranslated region and 
translation initiation codon, then either the fusion pro- 
tein derived from SM50- CAT is 34-fold less active than 
the enzyme derived from 2.2. CAT (i.e., 2.8 x 12, the 
average ratio of CAT enzyme activity per embryo in the 
2.2. CAT sample to that in the SMS0- CAT sample), or 
it is turned over in the cell 34 times more rapidly, or a 
combination of both. The extraneous amino-terminal 
SMS0 polypeptide sequence could be responsible for ei- 
ther phenomenon. However, it may seem a less than 
probable xplanation that a portion of the normal SM50 
protein sequence would result in an increase in turnover 
rate in cells that also express this protein endogenously. 
The more likely alternative is that the larger amino-ter- 
minal SM50 sequence causes teric hindrance of the en- 
zyme, resulting in >10 x lower acetylation activity 
compared to the fusion protein produced by 2.2. CAT, 
which includes but four SM50 amino acids. 
Thus, a conclusion from these CAT mRNA measure- 
ments is that quantitatively significant negative tran- 
scriptional regulatory sites are unlikely to be present in 
the large intron of the SM50 gene. We have seen that if 
anything the SM50. CAT gene is more active than the 
2.2. CAT gene, though the severalfold difference in 
transcript concentration is probably due simply to the 
subsaturation level of exogenous genes in this particular 
sample of 2.2. CAT embryos. An ancillary, though indi- 
rect argument to this effect, is that in experiment 1 of 
Table 1, for which there are neither CAT DNA nor CAT 
mRNA measurements, the ratio of CAT enzyme ac- 
tivity per embryo between the SM50. CAT and the 
2.2 • CAT constructs, i.e., 25 x, is close to the apparent 
ratio of CAT enzyme activity per transcript, i.e., 34 x. 
This is what would be expected were the exogenous 
DNA saturating in experiment 1, as is usually the case 
in sea urchin embryos raised from eggs injected in the 
cytoplasm by this method (Flytzanis et al. 1987; Lai et 
al. 1988; Livant et al. 1988), and were the two constructs 
exactly equal in transcriptional ctivity. In any case, the 
minimum qualitative conclusion is that these experi- 
ments provide no evidence for important regulatory se- 
quences located in the intron or in the exon sequences 
deleted in 2.2. CAT. As we now show, the necessary 
and sufficient sequences can be identified in the 
flanking upstream region of the SM50 gene. 
Subdivision of the upstream regulatory domain 
The 2.2-kb SalI fragment of 2.2. CAT was subcloned 
into a slightly different CAT vector known as 
pUC" PL. CAT (Bond-Matthews and Davidson 1988), to 
generate 2.2PL. CAT (Fig. lb). This construct is iden- 
tical to 2.2 • CAT in the SM50 upstream and coding se- 
quences it includes, and these SM50 sequences are fused 
to the parental CAT vector at the same SalI restriction 
site. The rationale for this construct is the presence in 
2.2PL • CAT of polylinker estriction sites at he 5' end 
of the SM50 sequence, permitting the entire insert of 
2.2PL. CAT to be excised as a SphI-BamHI fragment 
(Fig. lb). After gel purification the insert could then be 
injected without appended plasmid vector sequences. 
Several additional restriction fragments were likewise 
derived from 2.2PL • CAT that include progressively less 
5' SM50 promoter sequence, all of which terminate with 
the identical CAT-SV40 vector sequence (see Fig. lb). 
Injection of fragments bordered at the 5' end by the SphI 
site (at position -2200), the EcoRV site (at -1100), or 
the BglII site (at -440) resulted in a mild difference in 
CAT activity that was not statistically significant (Table 
2). The BglII-BamHI fragment was subcloned separately 
and again gel-purified to preclude the possibility of con- 
tamination, again with no difference observed in CAT 
activity compared to the SphI-BamHI fragment (Table 
2, experiment 2). Thus, the sequences upstream of the 
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Table 2. CAT enzyme activity in transgenic embryos bearing 
various 5' SM50. CAT deletions 
Fragment of 2.2PL • CAT CAT enzyme units/embryo (avJ b 
injected a expt. 1 expt. 2 
SphI-BamHI 1.6 x 10 -s 1.1 x 10 -s 
EcoRV-BamHI 1.8 x 10 -s 
BgRI-BamHI 1.9 x 10 -s 1.4 x 10 -s 
a See Fig. lb. 
b Each value represents he average of two  or three samples, ex- 
cept for the EcoRV-BamHI fragment (one sample}. Each sample 
contained 45-60 injected embryos. 
BgllI site of the SM50 promoter are dispensable, as as- 
sayed by CAT activity at the early pluteus stage. Further 
deletions do result in a significant decrease in CAT ac- 
tivity, confirming that important regulatory sequences 
required for SM50 function are found within the BgllI 
site {data not shown). 
To determine whether spatial regulation is main- 
tained after deletion of the SM50 promoter to the BglII 
site, embryos injected with the BglII-BamHI fragment 
were collected at mesenchyme blastula stage and pre- 
pared for in situ hybridization. Representative examples 
of sections are shown in Figure 5. Expression of this 
transgene is again l imited to ingressed mesen- 
chyme cells and to the polar region of the vegetal ecto- 
derm wall, i.e., the identical pattem observed with 
SM50. CAT. complete sections of 13 embryos were re- 
covered, and partial series {at least three sections) of an 
additional 24 embryos were examined as well. Fourteen 
displayed no labeled cells. Eight embryos howed label 
in ingressed mesenchyme c lls only, seven showed label 
over polar regions of the vegetal ectoderm wall only, and 
eight showed label over both. As seen in a few sections 
from embryos expressing SM50. CAT, several sections 
displayed label over regions of the embryo that were pos- 
sibly not mesenchyme or vegetal mesenchyme pre- 
Figure 5. In situ hybridization ofembryos expressing the BgIII-BamHI fragment of 2.2PL • CAT. (a-c} Embryos collected at mesen- 
chyme blastula stage; (d-e} embryo at early pluteus tage (60 hr of development}, seen in darkfield {d) and phase contrast {e). Mesen- 
chyme blastula-stage embryos are oriented with the vegetal pole at the bottom. In b, labeling can be seen in cells still within the 
vegetal wall that would shortly have ingressed into the blastocoel. The number of labeled mesenchyme c lls, and the number of 
mesenchyme c lls present is: (al 2 of 4, {b) 3 of 5, and (cl 3 of 7. The pluteus-stage embryo (which is slightly distorted from sectioning} 
is oriented with the vegetal pole down and the future site ofthe mouth at the top left. The cluster of mesenchyme c lls labeled in this 
section are located at the future apex of the pluteus. 
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cursors. In one case, two cells at the animal pole of the 
embryo were labeled, and in second case, a single cell at 
the lateral side of the vegetal plate was labeled. How- 
ever, the vast majority of embryos clearly demonstrated 
the correct expression pattern. As noted above (Fig. 3b), 
the observed frequency of labeled cells in the mesen- 
chyme population of these embryos was similar to that 
observed in embryos injected with SM50. CAT. 
Embryos bearing the BglII-BamHI fragment were also 
raised to early pluteus stage, and then collected for in 
situ hybridization. At this stage, the skeletogenic mes- 
enchyme cells have for the most part distributed them- 
selves along the length of the growing spicules, although 
small clusters of these cells persist at the ends of the 
spicule rods (Gustafson and Wolpert 1963). The ecto- 
derm and intestinal tract are close to fully differentiated, 
and migratory derivatives of the nonskeletogenic sec- 
ondary mesenchyme are apparent within the blastocoel. 
In sectioned embryos that displayed CAT mRNA, the 
label was again seen over mesenchyme cells, and was 
not present over gut or ectoderm cells. One example is 
shown in Figure 5, d-e. However, it is not possible to 
determine whether the labeled cells surround a spicule 
in vivo, in since the mineral elements of the skeleton are 
dissolved during fixation, and therefore it remains un- 
known whether the labeled cells were skeletogenic or 
secondary mesenchyme cells. It can be excluded, none- 
theless, that widespread ectopic expression of the trans- 
gene occurs in highly differentiated embryos. The unam- 
biguous results obtained with mesenchyme blastula 
stage embryos (Fig. 5a-c)provide the major conclusion 
from this initial dissection of the SM50 regulatory do- 
main. This is that the region which lies between the 
BglII site at position -440 and the SalI site at position 
+ 120 includes regulatory sequences that suffice to pro- 
mote correct spatial activation of this gene. 
Discussion 
Regulated expression of the SM50. CAT fusion in 
transgenic embryos 
This study demonstrates that the lineage-specific ex- 
pression of a gene required for mesenchymal skeleto- 
genesis in the embryo is mediated by cis-regulatory se- 
quences within a few hundred nucleotides of the initia- 
tion site of the gene. There could be additional 
quantitative r gulatory sites that we did not assay either 
upstream of -2200, or within the body of the gene that 
was replaced by the CAT reporter gene sequence in the 
fusion we studied. We have no way of directly com- 
paring the transcriptional ctivity of the CAT fusions 
with that of the native SM50 gene. This is because mul- 
tiple copies of the gene are incorporated, ue to the ini- 
tial concatenation of the injected molecules, and the 
subsequent replication of the concatenates along with 
the host cell genomes (Flytzanis et al. 1985; McMahon 
et al. 1985; Franks et al. 1988; Hough-Evans et al. 1988). 
However, the amount of expression obtained from the 
SM50. CAT fusions is consistent with expectation, were 
the number of exogenous genes saturating with respect 
to endogenous regulatory factors (Flytzanis et al. 1987). 
The measurements shown in Figure 4a indicate about 
8 x 10 4 molecules of the exogenous construct per em- 
bryo for the SM50 • CAT sample, or -10  s in those em- 
bryos that show SM50. CAT expression. The measure- 
ments of Figure 3 indicate that on the average these are 
located in 5.5/32 or 17.2% of the mesenchyme c lls. Ac- 
cepting this as an estimate for the whole embryo, in the 
-1000 cell early pluteus there would be about 500 fu- 
sion genes per cell, versus the two copies of the native 
SM50 gene per cell (Sucov et al. 1987). For comparison, 
Livant et al. (1988) showed that half-saturation of the 
expression of a fusion construct under control of the 
CyIIIa regulatory sequence occurs at -50 -200  fusion 
genes per cell depending on the batch of eggs. The 
amount of CAT mRNA we measured in the present 
work is about nine-fold greater than the amount of en- 
dogenous SM50 mRNA per cell. Thus, there would be 
about 1760 CAT mRNA molecules per active cell 
(1.8 X 104 CAT mRNA transcripts per embryo, divided 
by 60 skeletogenic mesenchyme c lls x 0.17), compared 
with about 200 SM50 mRNA molecules per skeleto- 
genic mesenchyme cell (Killian and Wilt 1988). The 
equivalent ratio for the CyIIIa. CAT fusion indicates 
that at saturation with exogenous genes about 20-fold 
more CAT mRNA is produced per aboral ectoderm cell 
bearing the CyIIIa • CAT fusion than endogenous CyIIIa 
mRNA (Flytzanis et al. 1987; Hough-Evans et al. 1988). 
Of course, to demonstrate that the incorporated SM50 
fusions do in fact titrate out the available factor(s) that 
interact with them would require direct in vivo satura- 
tion and competition measurements, as have been car- 
ried out with the CyIIIa gene (Flytzanis et al. 1987; Li- 
vant et al. 1988; R. Franks, unpubl.). We here rely, at 
least in part, on the quantitative similarity displayed by 
these two systems with respect o these measurements 
of reported gene activity. In summary, the level of ac- 
tivity observed in embryos bearing SM50. CAT con- 
structs is clearly not an inconsequential trickle, and 
could represent the maximum level of expression per- 
mitted by the concentrations of the available transcrip- 
tion factors. 
The main focus of this work has been the spatial 
rather than the quantitative regulation of the SMS0 
gene, as this displays so striking a lineage specificity. 
The preservation of this lineage specificity in the ex- 
pression of the SM50" CAT fusions implies that trans- 
acting factors recognizing the necessary regulatory ele- 
ments included in the fusion constructs must be local- 
ized, or activated, exclusively in the skeletogenic 
mesenchyme cell lineages, and that the causal basis of 
SMS0 expression in skeletogenic mesenchyme cells is 
the interaction of the factors with the cis-regulatory e- 
gions of this gene. We showed earlier that the identical 
CAT reporter construct is activated in a wholly exclu- 
sive set of embryonic lineages, the aboral ectoderm, 
when placed under the control of cis-regulatory se- 
quences of the CyIIIa cytoskeletal ctin gene, which is 
normally expressed only in aboral ectoderm (Flytzanis et 
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al. 1987; Hough-Evans et al. 1987, 1988). The compar- 
ison provides a strong argument that it is simply the 
spatial distribution of active forms of the respective reg- 
ulatory factors amongst the lineages of the early embryo 
that determines the initial pattern of differential gene 
expression. 
Autonomous and regulative differentiation of 
skeletogenic mesenchyme 
The simple paradigm just derived fits the normal differ- 
entiation of the skeletogenic mesenchyme lineage from 
its fifth-cleavage founder cells, since this lineage differ- 
entiates autonomously in vitro (see introductory section 
for references), and since experimental test excludes any 
requirement for (inductive) intercellular interactions in 
SMS0 expression by cells of this lineage {Stephens et al. 
1988). Thus, it is difficult to avoid the conclusion that 
localized maternal cytoplasmic factors that directly or 
indirectly cause skeletogenic gene expression are segre- 
gated to the skeletogenic mesenchyme founder cells in 
the course of the geometrically programmed cleavage di- 
visions by which they arise. On the other hand there 
have been reported many observations, classical and 
modern, that demonstrate a regulative potential for ske- 
letogenesis in lineages of the sea urchin embryo that 
never in normal development contribute to the skeleto- 
genic mesenchyme. H6rstadius and his school of experi- 
mentalists produced a number of different chimeric 
blastomere recombinations in which skeletogenesis ap- 
parently is carried out by progeny of tiers of cells not 
normally ancestral to skeletogenic mesenchyme (for re- 
view, see H6rstadius 1939, 1973). In addition, isolated 
animal-half embryos, which consist exclusively of cells 
that in normal development are ancestral to oral and 
aboral ectoderm, and to their neurogenic derivatives, can 
be induced to give rise to complete pluteus larvae that 
include normal formed skeletal structures, by treatment 
with LiC1 (yon Ubisch 1925a, b, 1929; H6rstadius 1973, 
Fig. 34). Furthermore, removal of ingressed skeletogenic 
mesenchyme c lls from within the blastocoel induces a 
quantitative, compensatory conversion of nonskeleto- 
genic secondary mesenchyme cells to the function of a 
skeletogenic lineage (Fukushi 1962; Ettensohn and 
McClay 1988). An apparent paradox arises from this evi- 
dence of widespread nonlocalized potential to produce 
skeletogenic cells, in considering results such as those 
presented here, that by logic generate the conclusion 
that normal specification of skeletogenic function is 
caused by the localization of regulatory factors which 
result in lineage-specific, differential gene expression. 
An interpretation of embryonic development that 
might afford a resolution of this elementary problem can 
be summarized in a few words as follows (space does not 
permit a detailed exposition, which is presented else- 
where). It is proposed that regulatory factors controlling 
spatial expression of lineage-specific genes may be dis- 
tributed globally in the embryo, but generally in an in- 
active state; that the location of cleavage planes (which 
in sea urchin embryos is per se a fixed property of the 
maternal cytoskeletal organization} sets up the lineage 
founder cell domains; and that specific ligand-receptor 
[inductivel interactions occurring during cleavage at the 
membranes eparating founder cells result by signal 
transduction, in alteration of regulatory factor state from 
inactive to active. In the unusual case of the normal ske- 
letogenic founder cells, the responsible factors would be 
in an active state irrespective of such interactions. The 
effects of the ectopic blastomere rearrangements, or of 
LiC1 treatment, can be interpreted as short-circuiting or
abnormally stimulating the signal transduction appa- 
ratus normally utilized for other purposes, in those blas- 
tomeres whose lineages are transformed by such treat- 
ment. The mysterious phenomenon of regulative devel- 
opment, which has puzzled observers ever since its 
discovery in the initial phase of experimental embry- 
ology a century ago (for review, see Wilson 1925, 
Chapters 13 and 14; Davidson 1986, Chapter 6), may be 
explained generally in a similar way. That is, the regula- 
tive capacity of given portions of an early embryo simply 
could reflect he distribution f trans-regulators that can 
be converted to active forms through the ectopic opera- 
tion of cell signaling systems utilized normally for 
founder cell specification. 
Mater ia ls  and methods  
Construction of SM50. CAT 
A genomic lone was isolated from the same sea urchin EMBL3 
genomic library as those described previously (Sucov et al. 
1987), and selected for its longer 5' end. The SalI-KpnI frag- 
ment containing the 5' portion of the SM50 gene was subcloned 
into pUC18, restricted at the KpnI site, and digested with 
Bal31. SalI linkers were added, the DNA restricted with SalI, 
and the fragments containing the SM50 gene sequences were 
cloned into pUC18. One clone terminated at the 3' end just 
within the SM50 second exon. Its insert was excised with SalI 
and cloned into a version of pSVOCAT (Gorman et al. 1982) 
modified so as to contain a SalI site at the junction of the CAT 
coding region (Katula et l. 1987}. The relevant sequence of this 
clone is shown in Figure lc. 
Construction of SM5OA. CAT 
A region of SM50. CAT containing the first exon was ub- 
cloned into Bluescfipt (Stratagene), and single-strand DNA was 
isolated according to recommended procedures. The 37-mer 
used for mutagenesis (Fig. ld) was synthesized atthe Caltech 
Microchemical Facility, and phosphorylated with polynucleo- 
tide kinase. An equimolar amount of template and oligo were 
mixed, denatured at 65°C for 5 min, and rehybridized at 37°C 
for 10 min. Extension with Klenow polymerase and deoxynu- 
cleotides, and recircularization by ligation were as recom- 
mended (Stratagene). The DNA was used to transform JM101. 
Following chloramphenicol amplification, colonies on replicate 
filters were screened with the 37-mer, labeled with polynucleo- 
tide kinase and [~/-a2P]ATP. Hybridization was at 65°C in 4 x 
SET, 5 x Denhardt's solution, 0.1% SDS, 25 mM phosphate 
buffer (pH 6.8}, and 50 v.g/ml denatured calf thymus DNA; the 
final wash was at 65°C in 0.3 x SET, 0.1% SDS, 25 mM phos- 
phate buffer, and 0.1% NaPPi. Approximately 1% of the recom- 
binant colonies had been mutagenized successfully. 
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Construction of 2.2. CAT and 2.2PL. CAT 
The 2.2-kb SalI fragment from SM50A. CAT was subcloned 
into pSVOCAT, modified to contain a SalI site by Flytzanis et 
al. (1987), to generate 2.2. CAT. The same fragment was in- 
serted into the CAT vector pUC. PL. CAT (Bond-Matthews 
and Davidson 1988), modified to create a SalI site by fill-in of 
the BglII site and attachment of SalI linkers, to generate 
2.2PL • CAT. 
Embryos 
S. purpuratus eggs were microinjected asdescribed (McMahon 
et al. 1985) with either BamHI-linearized plasmid DNA or gel- 
purified fragments. Approximately 1500 molecules of CAT- 
containing DNA were introduced per egg, with a fourfold molar 
excess of PstI restricted carrier sea urchin genomic DNA par- 
tially digested to an average length of 10 kb. The inclusion of 
carrier DNA augments expression (R. Franks, unpubl.). For 
CAT assays, embryos were collected at prism stage and assayed 
by standard procedures, as described by Franks et al. (1988). For 
in situ analysis, amethod to simplify the collection of the rela- 
tively small number of injected embryos was developed. Thirty 
microliters of molten 1.5% agarose in seawater was allowed to 
harden in the bottom of a siliconized 200-~1 yellow pipet tip. 
Embryos were transferred into approximately 100 ~l of sea- 
water overlying the agarose cushion, then spun in a Beckman 
microfuge with an Eppendorf tube as a holder at setting 3 for 2 
min. As much of the overlying seawater as possible was aspi- 
rated with a drawn-out Pasteur pipette under a dissecting mi- 
croscope. Seven microliters of molten agarose in seawater was 
used to resuspend the loose embryo pellet. The yellow tip was 
held in ice-cold seawater for 20 sec to harden the agarose, then 
cut with a razor. The chunk containing the embryos was 
pushed into glutaraldehyde fix buffer and further processed and 
paraffin-embedded as described by Hough-Evans et al. (1987). 
All sections were cut at 5 ~m. Hybridization was as described 
by Hough-Evans et al. (1987). 
Probe excess RNA titration 
Embryos were harvested 50 hr after injection, at the early 
pluteus tage of development. Aliquots were removed for anal- 
ysis of CAT activity (quantitated in Table 1 as experiments 2 
and 3) and of DNA content, the latter measured by a procedure 
described by Franks et al. (1988). Briefly, DNA was isolated 
from embryo pellets by proteinase K digestion and organic ex- 
traction, then denatured and affixed to nitrocellulose using a 
slot blot apparatus. The filter was hybridized with a single- 
strand SP6-derived RNA probe containing only CAT sequences 
at 42°C in 50% formamide, 5 x SSC, 1 x Denhardt's solution, 
20 rnM phosphate buffer, and 50 ~g/ml calf thymus DNA; the 
final wash was at 60°C in 1 x SSC, 0.2% SDS. For isolation of 
RNA, 1455 experimental embryos were mixed with a 13-fold 
excess of uninjected embryos, pelleted, and frozen dry. Eighty 
percent of the experimental embryos are derived from experi- 
ment 2 of Table 1, the remainder f om experiment 3. Embryo 
pellets were resuspended in a urea sarcosine buffer and digested 
with proteinase K as described by Lee et al. (1986), followed by 
organic extraction and ethanol precipitation. Nucleic acids 
were twice digested for 1 hr with 4 units of RNase-free DNase 
{RQ1, Promega) with the addition of 40 units RNasin (Promega) 
and 5 mM DTT, extracted, and precipitated. RNA recovery was 
40-50 ~g. Probe excess titration was exactly as described by 
Lee et al. (1986), using SP6-transcribed RNA probes labeled 
with 800 Ci/mmole [32p]rUTP. The 131-nucleotide CyIIIa probe 
is described by Lee et al. (1986); the CAT probe was derived 
Expression of a sea urchin skeletogenic transgene 
from the SalI-BalI fragment of pSVOCAT and contains only 
CAT sequences. Data reduction was as described by Lee et al. 
(1986). 
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